Detalles de la búsqueda
1.
Lean Indian patients with non-alcoholic fatty liver disease (NAFLD) have less metabolic risk factors but similar liver disease severity as non-lean patients with NAFLD.
Int J Obes (Lond)
; 47(10): 986-992, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37474570
2.
Sofosbuvir and Velpatasvir combination is safe and effective in treating chronic hepatitis C in end-stage renal disease on maintenance haemodialysis.
Liver Int
; 41(4): 705-709, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33025685
3.
Substantial overlap between NAFLD and MASLD with comparable disease severity and non-invasive test performance: an analysis of the Indian Consortium on MASLD (ICOM-D) cohort.
J Hepatol
; 2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38801919
4.
Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD.
J Hepatol
; 80(2): e61-e62, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558135
5.
Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.
Dig Dis Sci
; 63(5): 1334-1340, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29484572
6.
NAFLD vs. MAFLD - It is not the name but the disease that decides the outcome in fatty liver.
J Hepatol
; 76(2): 475-477, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34530064
7.
Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C.
J Gastroenterol Hepatol
; 32(4): 859-863, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27624314
8.
Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study.
Aliment Pharmacol Ther
; 59(6): 774-788, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38303507
9.
Infrared spectroscopic laser scanning confocal microscopy for whole-slide chemical imaging.
Nat Commun
; 14(1): 5215, 2023 08 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626026
10.
FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort.
J Clin Exp Hepatol
; 12(2): 440-447, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535068
11.
Clinicopathological Profile and Outcome of a Large Cohort of Patients with Nonalcoholic Fatty Liver Disease from South Asia: Interim Results of the Indian Consortium on Nonalcoholic Fatty Liver Disease.
Metab Syndr Relat Disord
; 20(3): 166-173, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085026
12.
Association between nonalcoholic fatty liver disease and inflammatory periodontal disease: A casecontrol study.
J Indian Soc Periodontol
; 25(1): 47-54, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33642741
13.
High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study.
BMJ Open Gastroenterol
; 6(1): e000315, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31423319
14.
Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease.
J Clin Exp Hepatol
; 9(1): 22-28, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30765935
15.
Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.
JGH Open
; 1(2): 62-67, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30483536
16.
Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?
J Clin Exp Hepatol
; 7(2): 121-126, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28663676
17.
Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care center.
Hepatol Int
; 9(2): 283-91, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25788200
Resultados
1 -
17
de 17
1
Próxima >
>>